RFS Pharma, LLC is a clinical-stage biopharmaceutical company founded by Dr. Raymond F. Schinazi to develop new drugs for the treatment of hepatitis infections as well as emerging viruses. Located in a laboratory facility in suburban Atlanta, RFS Pharma will continue to provide growth to the pharmaceutical industry in Georgia.
RFS Pharma was incorporated in 2004 and in-licensed anti-hepatitis technology from Emory University in 2013.
In addition to its own pipeline, RFS Pharma is actively seeking promising new drugs for in-licensing.